vs
PTC THERAPEUTICS, INC.（PTCT）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Rocket Lab Corp的季度营收约是PTC THERAPEUTICS, INC.的1.1倍（$179.7M vs $164.7M），Rocket Lab Corp净利率更高（-29.5% vs -82.0%，领先52.5%），Rocket Lab Corp同比增速更快（35.7% vs -22.7%），PTC THERAPEUTICS, INC.自由现金流更多（$-36.6M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs -11.5%）
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
PTCT vs RKLB — 直观对比
营收规模更大
RKLB
是对方的1.1倍
$164.7M
营收增速更快
RKLB
高出58.5%
-22.7%
净利率更高
RKLB
高出52.5%
-82.0%
自由现金流更多
PTCT
多$77.5M
$-114.2M
两年增速更快
RKLB
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $164.7M | $179.7M |
| 净利润 | $-135.0M | $-52.9M |
| 毛利率 | — | 38.0% |
| 营业利润率 | -43.3% | -28.4% |
| 净利率 | -82.0% | -29.5% |
| 营收同比 | -22.7% | 35.7% |
| 净利润同比 | -104.8% | -1.1% |
| 每股收益（稀释后） | $-1.63 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTCTRKLB
| Q4 25 | $164.7M | $179.7M | ||
| Q3 25 | $211.0M | $155.1M | ||
| Q2 25 | $178.9M | $144.5M | ||
| Q1 25 | $1.2B | $122.6M | ||
| Q4 24 | $213.2M | $132.4M | ||
| Q3 24 | $196.8M | $104.8M | ||
| Q2 24 | $186.7M | $106.3M | ||
| Q1 24 | $210.1M | $92.8M |
净利润PTCTRKLB
| Q4 25 | $-135.0M | $-52.9M | ||
| Q3 25 | $15.9M | $-18.3M | ||
| Q2 25 | $-64.8M | $-66.4M | ||
| Q1 25 | $866.6M | $-60.6M | ||
| Q4 24 | $-65.9M | $-52.3M | ||
| Q3 24 | $-106.7M | $-51.9M | ||
| Q2 24 | $-99.2M | $-41.6M | ||
| Q1 24 | $-91.6M | $-44.3M |
毛利率PTCTRKLB
| Q4 25 | — | 38.0% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 28.8% | ||
| Q4 24 | — | 27.8% | ||
| Q3 24 | — | 26.7% | ||
| Q2 24 | — | 25.6% | ||
| Q1 24 | — | 26.1% |
营业利润率PTCTRKLB
| Q4 25 | -43.3% | -28.4% | ||
| Q3 25 | 1.4% | -38.0% | ||
| Q2 25 | -19.5% | -41.3% | ||
| Q1 25 | 82.5% | -48.3% | ||
| Q4 24 | -76.2% | -38.9% | ||
| Q3 24 | -27.7% | -49.5% | ||
| Q2 24 | -21.5% | -40.7% | ||
| Q1 24 | -21.6% | -46.4% |
净利率PTCTRKLB
| Q4 25 | -82.0% | -29.5% | ||
| Q3 25 | 7.5% | -11.8% | ||
| Q2 25 | -36.3% | -46.0% | ||
| Q1 25 | 73.7% | -49.5% | ||
| Q4 24 | -30.9% | -39.5% | ||
| Q3 24 | -54.2% | -49.6% | ||
| Q2 24 | -53.1% | -39.2% | ||
| Q1 24 | -43.6% | -47.7% |
每股收益（稀释后）PTCTRKLB
| Q4 25 | $-1.63 | $-0.09 | ||
| Q3 25 | $0.20 | $-0.03 | ||
| Q2 25 | $-0.83 | $-0.13 | ||
| Q1 25 | $10.04 | $-0.12 | ||
| Q4 24 | $-0.85 | $-0.11 | ||
| Q3 24 | $-1.39 | $-0.10 | ||
| Q2 24 | $-1.29 | $-0.08 | ||
| Q1 24 | $-1.20 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $-205.3M | $1.7B |
| 总资产 | $2.9B | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资PTCTRKLB
| Q4 25 | $1.9B | $1.0B | ||
| Q3 25 | $1.7B | $976.7M | ||
| Q2 25 | $2.0B | $688.1M | ||
| Q1 25 | $2.0B | $428.4M | ||
| Q4 24 | $1.1B | $419.0M | ||
| Q3 24 | $1.0B | $442.4M | ||
| Q2 24 | $1.1B | $496.8M | ||
| Q1 24 | $884.8M | $492.5M |
总债务PTCTRKLB
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益PTCTRKLB
| Q4 25 | $-205.3M | $1.7B | ||
| Q3 25 | $-155.8M | $1.3B | ||
| Q2 25 | $-206.5M | $688.5M | ||
| Q1 25 | $-185.8M | $431.3M | ||
| Q4 24 | $-1.1B | $382.5M | ||
| Q3 24 | $-1.1B | $419.8M | ||
| Q2 24 | $-980.2M | $455.2M | ||
| Q1 24 | $-893.9M | $478.9M |
总资产PTCTRKLB
| Q4 25 | $2.9B | $2.3B | ||
| Q3 25 | $2.6B | $2.2B | ||
| Q2 25 | $2.6B | $1.6B | ||
| Q1 25 | $2.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.8B | $1.2B | ||
| Q2 24 | $1.9B | $1.2B | ||
| Q1 24 | $1.8B | $1.2B |
负债/权益比PTCTRKLB
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-34.3M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $-36.6M | $-114.2M |
| 自由现金流率自由现金流/营收 | -22.3% | -63.6% |
| 资本支出强度资本支出/营收 | 1.4% | 27.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $702.3M | $-321.8M |
8季度趋势，按日历期对齐
经营现金流PTCTRKLB
| Q4 25 | $-34.3M | $-64.5M | ||
| Q3 25 | $-66.3M | $-23.5M | ||
| Q2 25 | $-58.3M | $-23.2M | ||
| Q1 25 | $870.1M | $-54.2M | ||
| Q4 24 | $-30.0M | $-2.4M | ||
| Q3 24 | $-77.0M | $-30.9M | ||
| Q2 24 | $-71.5M | $-13.0M | ||
| Q1 24 | $70.8M | $-2.6M |
自由现金流PTCTRKLB
| Q4 25 | $-36.6M | $-114.2M | ||
| Q3 25 | $-69.7M | $-69.4M | ||
| Q2 25 | $-59.6M | $-55.3M | ||
| Q1 25 | $868.4M | $-82.9M | ||
| Q4 24 | $-33.8M | $-23.9M | ||
| Q3 24 | $-77.5M | $-41.9M | ||
| Q2 24 | $-78.8M | $-28.3M | ||
| Q1 24 | $61.2M | $-21.8M |
自由现金流率PTCTRKLB
| Q4 25 | -22.3% | -63.6% | ||
| Q3 25 | -33.1% | -44.8% | ||
| Q2 25 | -33.3% | -38.3% | ||
| Q1 25 | 73.8% | -67.6% | ||
| Q4 24 | -15.8% | -18.1% | ||
| Q3 24 | -39.4% | -40.0% | ||
| Q2 24 | -42.2% | -26.7% | ||
| Q1 24 | 29.1% | -23.5% |
资本支出强度PTCTRKLB
| Q4 25 | 1.4% | 27.6% | ||
| Q3 25 | 1.6% | 29.6% | ||
| Q2 25 | 0.7% | 22.2% | ||
| Q1 25 | 0.1% | 23.4% | ||
| Q4 24 | 1.8% | 16.3% | ||
| Q3 24 | 0.3% | 10.5% | ||
| Q2 24 | 4.0% | 14.4% | ||
| Q1 24 | 4.6% | 20.7% |
现金转化率PTCTRKLB
| Q4 25 | — | — | ||
| Q3 25 | -4.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTCT
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
